Cuprizone‐mediated demyelination reversibly degrades voiding behavior in mice while sparing brainstem reflex

• Published in: Journal of neuroscience research 2022-09, Vol.100 (9), p.1707-1720
• Main Authors: Ramasamy, Ramalakshmi, Hardy, Cara C., Crocker, Stephen J., Smith, Phillip P.
• Format: Article
• Language: English
• Subjects: Animal models; Autoimmunity; Bladder; bladder dysfunction; Brain stem; Central nervous system; Circuits; conscious urinary behavior; Corpus callosum; Cuprizone; cystometry; Demyelinating diseases; Demyelination; Diet; Inflammation; Multiple sclerosis; Myelination; Phenotypes; Quality of life; RRID:SCR_001620; RRID:SCR_002285; RRID:SCR_002798; Spinal cord; Urinary tract; Urination
• ISSN: 0360-4012; 1097-4547
• DOI: 10.1002/jnr.25065

Multiple sclerosis (MS) is a chronic, progressively debilitating demyelinating disease of the central nervous system (CNS). Nearly 80% of MS patients experience lower urinary tract dysfunction early in their diagnosis. This significantly affects the quality of life, and in latter stages of disease is a leading cause of hospitalization. Previously, animal models have shown that inflammatory demyelination in the CNS causes profound bladder dysfunction, but the confounding influence of systemic inflammation limits the potential interpretation of the contribution of CNS demyelination to bladder dysfunction. Since the micturition circuit has myelinated neuronal connections in the cortex, brainstem, and spinal cord, we examined alterations in bladder function in the cuprizone model characterized by demyelinating lesions in the cortex and corpus callosum that are independent of T‐cell–mediated autoimmunity. Herein, we report that a 4‐week dietary cuprizone treatment in C57Bl/6J mice induced alterations in voiding behavior with increased micturition frequency and reduced volume voided, similar to human MS bladder dysfunction. Subsequently, recovery from cuprizone treatment restored normal bladder function. Demyelination and remyelination were confirmed by Luxol Fast Blue staining of the corpus callosum. Additionally, we also determined that an 8‐week cuprizone treatment, resulting in chronic demyelination lacking spontaneous remyelination potential, is associated with an exacerbated voiding phenotype. Interestingly, while cuprizone‐induced CNS demyelination severely affected conscious (cortical) urinary behavior, the brainstem and spinal cord reflex remained unchanged, as confirmed by urethane‐anesthetized cystometry. This is the first study to show that cortical demyelination independent of inflammation can negatively impact urinary function. We have determined cuprizone demyelination and remyelination is correlated with a loss and restoration of bladder continence. Interestingly, while cuprizone‐induced CNS demyelination severely affected conscious (cortical) urinary behavior, the brainstem and spinal cord reflex remained unchanged. Hence, these data indicate a role for cortical demyelination in the control of bladder function with potential implications understanding of urinary incontinence in a range of neurological disease states.